Thymectomy for myasthenia gravis
Analysis of the controversies regarding technique and results
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Thymectomy is effective in the treatment of myasthenia gravis (MG) and, in the opinion of many, should be the cornerstone of therapy for patients with generalized symptoms. Controversy persists, however, as to which operation is the procedure of choice. To resolve this controversy, those analyzing the results of thymectomy must understand the reasons for the differing opinions, the goal of surgery, the potential of the various surgical techniques for achieving total thymectomy, and the problems in the analysis of results. This report discusses these problems and presents evidence that there is a direct relationship between the extent of thymic resection and the results obtained.
Although arguments may be presented to refute some of the statements herein, it is hoped that this analysis will lead to better understanding and to resolution of the controversy, standardization of measurements, and the adoption of accepted analytic techniques.
Technical goal of thymectomy.
The technical goal of thymectomy in the treatment of MG is complete removal of all thymic tissue. [1-15] It is established that the thymus plays a central role in the pathogenesis of this autoimmune illness. Pathologic and immunologic studies support this thesis. [16-18] Complete neonatal thymectomy prevents experimental autoimmune myasthenia gravis, whereas incomplete removal does not. [19] In addition, clinically incomplete resections have been a cause of failure requiring reoperation. [20-24] As little as 3 g of residual thymus has caused severe symptoms, and its removal was therapeutic. [21]
Why the controversy?
Contrary to common perception, the anatomy of the human thymus is complex. It consists of multiple lobes in the neck and mediastinum, often not contiguous, as well as gross and microscopic thymic tissue widely and invisibly distributed in cervical and mediastinal fat [25] (Figure 1). Complete removal cannot be ascertained by visual inspection at surgery, and gross and microscopic thymic tissue may be overlooked unless en bloc resection …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Technical goal of thymectomy.
- Why the controversy?
- Potential of the surgical techniques in achievement of total thymectomy.
- Analysis of data is frequently flawed.
- "Maximal" thymectomy results.
- The extent of resection makes a difference.
- Comparison of results.
- Unanswered questions.
- Summary and recommendations.
- Acknowledgments
- REFERENCES
- Figures & Data
- Info & Disclosures
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Research Article
Impact of the Surgical Approach to Thymectomy Upon Complete Stable Remission Rates in Myasthenia GravisA Meta-analysisPaola Solis-Pazmino, Ioana Baiu, Eddy Lincango-Naranjo et al.Neurology, May 04, 2021 -
Articles
Myasthenia gravis with thymomaRobert E. Lovelace, David S. Younger et al.Neurology, April 01, 1997 -
Views & Reviews
International Consensus Guidance for Management of Myasthenia Gravis2020 UpdatePushpa Narayanaswami, Donald B. Sanders, Gil Wolfe et al.Neurology, November 03, 2020 -
Five New Things
Myasthenia gravisFive new thingsJeffrey M. Statland, Emma Ciafaloni et al.Neurology: Clinical Practice, April 15, 2013